CognomIQ

Healthcare data infrastructure is being rebuilt.

CognomIQ is a data operating platform built by healthcare professionals for the AI era of healthcare.

The platform has been deployed in full production for the past four years with national oncology validation and industry recognition. CognomIQ is now commercializing quietly with senior healthcare and enterprise data executives as it expands across NCI centers, health systems, and pharmaceutical organizations.

The company intentionally maintains a discreet online presence, and its website does not display customer logos.

Platform Impact

The CognomIQ platform has already powered more than 100 peer reviewed publications.

It supported the University of Rochester in achieving the prestigious #73 National Cancer Institute designation.

The platform has demonstrated the ability to save seven figures annually by replacing more than two dozen SaaS tools.

It has also proven capable of accelerating research, clinical trials, operations, and workflow by fifteen times or more.

Technology

CognomIQ ingests hundreds of disparate data sources using a proprietary real time semantic engine that strips, cleans, validates, and normalizes data into a single source of truth in real time.

This capability goes far beyond what artificial intelligence alone can achieve. According to the company, no other organization including Palantir, IQVIA, NVIDIA, AWS, Snowflake, or Databricks currently matches the speed, efficiency, accuracy, or return on investment delivered by the CognomIQ platform.

The company has already declined a previous acquisition offer.

Strategic Alignment Opportunity

As institutional momentum continues to grow, CognomIQ is aligning a small group of executives at the boardroom level to support the company’s next phase of national expansion.

Ideal Participants

This opportunity is designed for individuals who have led enterprise healthcare or data transformation initiatives.

Candidates should operate at a governance or board level and understand healthcare research economics and procurement cycles.

The company is particularly interested in leaders who recognize infrastructure level platforms before mainstream market adoption.

Structure

This engagement represents a strategic board level alignment connected to the company’s current Preferred Equity round.

Participation is structured exclusively for senior level involvement. Qualified executives will receive additional information following review.

‍